Nevertheless, there are cases of insulinopenic phenotypes where insulin becomes of fundamental use; think of patients with diabetes secondary to pancreaticoduodenectomy, patients with LADA and low c-peptide levels, patients with severe sarcopenia or with side effects and contraindications to GLP1RA or SGLT2i. The gene discussed is INS; the disease is sarcopenia.